Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats

Anesthesia and Analgesia

Volumn 96, Issue 4, 2003, Pages 1155-1160

  Li, Bai Han ^a   Lohmann, Jeffrey S ^a   Schuler, H Gregg ^a   Cronin, Arthur J ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; KETAMINE; PENTOBARBITAL; PROPOFOL; REMIFENTANIL; VECURONIUM;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; EVOKED SOMATOSENSORY RESPONSE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037378630     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000053239.62623.32     Document Type: Article

References (28)

1. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.
2. Bol CJ, Vogelaar JP, Mandema JW. Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. J Pharmacol Exp Ther 1999;291:153-60.
3. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302-8.
4. Maze M, Scarfini C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin 2001;17:881-97.
5. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001;87:684-90.
6. Hayton SM, Kriss A, Muller DP. Comparison of the effects of four anaesthetic agents on somatosensory evoked potentials in the rat. Lab Anim 1999;33:243-51.
7. Thornton C, Lucas MA, Newton DE, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. II. Auditory and somatosensory evoked responses. Br J Anaesth 1999;83:381-6.
8. Bloom M, Beric A, Bekker A. Dexmedetomidine infusion and somatosensory evoked potentials. J Neurosurg Anesthesiol 2001;13:320-2.
9. Peterson DO, Drummond JC, Todd MM. Effects of halothane, enflurane, isoflurane, and nitrous oxide on somatosensory evoked potentials in humans. Anesthesiology 1986;65:35-40.
10. Sloan TB. Anesthetic effects on electrophysiologic recordings. J Clin Neurophysiol 1998;15:217-26.
11. Koht A, Schutz W, Schmidt G, et al. Effects of etomidate, midazolam, and thiopental on median nerve somatosensory evoked potentials and the additive effects of fentanyl and nitrous oxide. Anesth Analg 1988;67:435-41.
12. Taniguchi M, Nadstawek J, Pechstein U, Schramm J. Total intravenous anesthesia for improvement of intraoperative monitoring of somatosensory evoked potentials during aneurysm surgery. Neurosurgery 1992;31:891-7; Discussion 897.
13. Bol CJJG, Danhof M, Stanski DR, Mandema JW. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. J Pharmacol Exp Ther 1997;283:1051-8.
14. Zentner J, Albrecht T, Heuser D. Propofol increases amplitudes of SEP. Funct Neurol 1991;6:411-2.
15. Scheepstra GL, de Lange JJ, Booij LH, Ros HH. Median nerve evoked potentials during propofol anaesthesia. Br J Anaesth 1989;62:92-4.
16. Drummond JC, Todd MM, U HS. The effect of high dose sodium thiopental on brain stem auditory and median nerve somatosensory evoked responses in humans. Anesthesiology 1985;63:249-54.
17. Tomoda K, Shingu K, Osawa M, et al. Comparison of CNS effects of propofol and thiopentone in cats. Br J Anaesth 1993;71:383-7.
18. Goss-Sampson MA, Kriss A. Effects of pentobarbital and ketamine-xylazine anaesthesia on somatosensory, brainstem auditory and peripheral sensory-motor responses in the rat. Lab Anim 1991;25:360-6.
19. Schubert A, Licina MG, Lineberry PJ. The effect of ketamine on human somatosensory evoked potentials and its modification by nitrous oxide. Anesthesiology 1990;72:33-9.
20. Marietta MP, Way WL, Castagnoli N Jr, Trevor AJ. On the pharmacology of the ketamine enantiomorphs in the rat. J Pharmacol Exp Ther 1977;202:157-65.
21. Samra SK, Dy EA, Welch KB, et al. Remifentanil- and fentanyl-based anesthesia for intraoperative monitoring of somatosensory evoked potentials. Anesth Analg 2001;92:1510-5.
22. Crabb I, Thornton C, Konieczko KM, et al. Remifentanil reduces auditory and somatosensory evoked responses during isoflurane anaesthesia in a dose-dependent manner. Br J Anaesth 1996;76:795-801.
23. Aho M, Erkola O, Kallio A, et al. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg 1992;75:940-6.
24. Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. J Clin Anesth 1999;11:466-70.
25. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. I. Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999;83:372-80.
26. Schmeling WT, Ganjoo P, Staunton M, et al. Pretreatment with dexmedetomidine: altered indices of anesthetic depth for halothane in the neuraxis of cats. Anesth Analg 1999;88:625-32.
27. Peden CJ, Cloote AH, Stratford N, Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia 2001;56:408-13.
28. Salmenpera MT, Szlam F, Hug CC Jr. Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs. Anesthesiology 1994;80:837-46.